Blue Water Vaccines Inc (BWV) Stock
BWV is no longer traded. Blue Water Vaccines was delisted from the Nasdaq in February 2024.
Prices on this page are historical; the last trade was February 22, 2024 at $0.17.
Blue Water Vaccines stock price history
BWV final trading statistics
- Final close
- $0.17
- Final trading day
- Feb 22, 2024
- Market cap at delisting
- $3.14M
- Shares outstanding
- 18.90M
- Final 52-week range
- $0.15 – $1.58
- Avg. volume (final 3 mo.)
- 4,009,776
- All-time high (split-adj.)
- $79.74 · Mar 2018
- All-time low (split-adj.)
- $0.15 · Jan 2024
- Return since IPO
- -99.7%
- Beta
- —
- Book value / share
- $0.57
- Price / book
- 0.29
Blue Water Vaccines annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $0.00 | -$18.3M | — |
| FY2022 | $0.00 | -$13.3M | -$1.23 |
| FY2021 | $0.00 | -$3.4M | -$0.09 |
| FY2020 | $0.00 | -$1.6M | — |
| FY2019 | $0.00 | -$763.6K | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Blue Water Vaccines Inc
Blue Water Biotech, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns ENTADFI, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Vaccines, Inc. and changed its name to Blue Water Biotech, Inc. in April 2023. Blue Water Biotech, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
Blue Water Vaccines stock FAQ
What happened to Blue Water Vaccines stock?
Blue Water Vaccines stock was delisted from the Nasdaq. Its final close was $0.17 on February 22, 2024.
Is BWV stock still trading?
No. BWV was delisted from the Nasdaq in February 2024 and no longer trades on a U.S. exchange.
What was the last price of BWV stock?
BWV closed at $0.17 on its final trading day, February 22, 2024, for a market value of about $3.14M.
What were Blue Water Vaccines's revenue and earnings in its last full fiscal year?
Blue Water Vaccines reported revenue of $0.00 and net income of -$18.3M in fiscal 2023, its last full year as a public company.
When did Blue Water Vaccines go public?
Blue Water Vaccines Inc stock began trading on February 18, 2022.